Epigenetic effects of green tea polyphenols in cancer

Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

References

• 1  Baylin SB, Jones PA. A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer11,726–734 (2011).
  Medline CASGoogle Scholar
• 2  Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature447,433–440 (2007).
  Medline CASGoogle Scholar
• 3  Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat. Rev. Genet.7,21–33 (2006).
  Medline CASGoogle Scholar
• 4  Ptak C, Petronis A. Epigenetics and complex disease: from etiology to new therapeutics. Annu. Rev. Pharmacol. Toxicol.48,257–276 (2008).
  Medline CASGoogle Scholar
• 5  Bird A. DNA methylation patterns and epigenetic memory. Genes Dev.16,6–21 (2002).
  Medline CASGoogle Scholar
• 6  Wang Y, Leung FC. An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics20,1170–1177 (2004).
  Medline CASGoogle Scholar
• 7  Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet.9,465–476 (2008).
  Medline CASGoogle Scholar
• 8  Dawson MA, Kouzarides T. Cancer epigenetics: from mechanism to therapy. Cell150,12–27 (2012).
  Medline CASGoogle Scholar
• 9  Meeran SM, Ahmed A, Tollefsbol TO. Epigenetic targets of bioactive dietary components for cancer prevention and therapy. Clin. Epigenetics1,101–116, (2010).
  Medline CASGoogle Scholar
• 10  Chervona Y, Costa M. Histone modifications and cancer: biomarkers of prognosis? Am. J. Cancer Res.2,589–597 (2012).
  Medline CASGoogle Scholar
• 11  Kala R, Peek GW, Hardy TM, Tollefsbol TO. MicroRNAs: an emerging science in cancer epigenetics. J. Clin. Bioinforma.3,6 (2013).
  Medline CASGoogle Scholar
• 12  Link A, Balaguer F, Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem. Pharmacol.80,1771–1792 (2010).
  Medline CASGoogle Scholar
• 13  Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: an interplay of dietary methyl donors, one-carbon metabolism and DNA methylation. J. Nutr. Biochem.23,853–859 (2012).
  Medline CASGoogle Scholar
• 14  Gerhauser C. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges. Top. Curr. Chem.329,73–132 (2013).
  Medline CASGoogle Scholar
• 15  Hardy TM, Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics3,503–518 (2011).
  CASGoogle Scholar
• 16  Szarc vel Szic K, Ndlovu MN, Haegeman G, Vanden BW. Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders. Biochem. Pharmacol.80,1816–1832 (2010).
  Medline CASGoogle Scholar
• 17  Stefanska B, Karlic H, Varga F, Fabianowska-Majewska K, Haslberger A. Epigenetic mechanisms in anti-cancer actions of bioactive food components – the implications in cancer prevention. Br. J. Pharmacol.167,279–297 (2012).
  Medline CASGoogle Scholar
• 18  Park LK, Friso S, Choi SW. Nutritional influences on epigenetics and age-related disease. Proc. Nutr. Soc.71,75–83 (2012).
  Medline CASGoogle Scholar
• 19  Siedlecki P, Zielenkiewicz P. Mammalian DNA methyltransferases. Acta Biochim. Pol.53,245–256 (2006).
  Medline CASGoogle Scholar
• 20  Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem.74,481–514, (2005).
  Medline CASGoogle Scholar
• 21  Jones PA, Liang G. Rethinking how DNA methylation patterns are maintained. Nat. Rev. Genet.10,805–811, (2009).
  Medline CASGoogle Scholar
• 22  Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat. Rev. Genet.11,204–220 (2010).
  Medline CASGoogle Scholar
• 23  Baccarelli A, Ghosh S. Environmental exposures, epigenetics and cardiovascular disease. Curr. Opin. Clin. Nutr. Metab. Care15,323–329 (2012).
  Medline CASGoogle Scholar
• 24  Wierda RJ, Geutskens SB, Jukema JW, Quax PH, van den Elsen PJ. Epigenetics in atherosclerosis and inflammation. J. Cell. Mol. Med.14,1225–1240 (2010).
  Medline CASGoogle Scholar
• 25  Bramswig NC, Kaestner KH. Epigenetics and diabetes treatment: an unrealized promise? Trends Endocrinol. Metab.23,286–291 (2012).
  Medline CASGoogle Scholar
• 26  Simmons R. Epigenetics and maternal nutrition: nature v. nurture. Proc. Nutr. Soc.70,73–81 (2011).
  Medline CASGoogle Scholar
• 27  Babenko O, Kovalchuk I, Metz GA. Epigenetic programming of neurodegenerative diseases by an adverse environment. Brain Res.1444,96–111 (2012).
  Medline CASGoogle Scholar
• 28  Das PM, Singal R. DNA methylation and cancer. J. Clin. Oncol.22,4632–4642 (2004).
  Medline CASGoogle Scholar
• 29  Khavan-Niaki H, Samadani AA. DNA methylation and cancer development: molecular mechanism. Cell Biochem. Biophys. (2013) (Epub ahead of print).
  Google Scholar
• 30  Watanabe Y, Maekawa M. Methylation of DNA in cancer. Adv. Clin. Chem.52,145–167 (2010).
  Medline CASGoogle Scholar
• 31  Heichman KA, Warren JD. DNA methylation biomarkers and their utility for solid cancer diagnostics. Clin. Chem. Lab. Med.50,1707–1721 (2012).
  Medline CASGoogle Scholar
• 32  Yang B, Sun H, Lin W et al. Evaluation of global DNA hypomethylation in human prostate cancer and prostatic intraepithelial neoplasm tissues by immunohistochemistry. Urol. Oncol.31(5),628–634 (2013).
  Medline CASGoogle Scholar
• 33  Liu L, Kron KJ, Pethe VV et al. Association of tissue promoter methylation levels of APC, TGFbeta2, HOXD3 and RASSF1A with prostate cancer progression. Int. J. Cancer129,2454–2462 (2011).
  Medline CASGoogle Scholar
• 34  Tokumaru Y, Harden SV, Sun DI, Yamashita K, Epstein JI, Sidransky D. Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma. Clin. Cancer Res.10,5518–5522 (2004).
  Medline CASGoogle Scholar
• 35  Ho E, Beaver LM, Williams DE, Dashwood RH. Dietary factors and epigenetic regulation for prostate cancer prevention. Adv. Nutr.2,497–510 (2011).
  Medline CASGoogle Scholar
• 36  Nowsheen S, Aziz K, Tran PT, Gorgoulis VG, Yang ES, Georgakilas AG. Epigenetic inactivation of DNA repair in breast cancer. Cancer Lett. doi:10.1016/j.canlet.2012.05.015 (2012) (Epub ahead of print).
  Google Scholar
• 37  Khan SI, Aumsuwan P, Khan IA, Walker LA. Dasmahapatra AK. Epigenetic events associated with breast cancer and their prevention by dietary components targeting the epigenome. Chem. Res. Toxicol.25,61–73 (2012).
  Medline CASGoogle Scholar
• 38  Sharma V, Rao LJ. A thought on the biological activities of black tea. Crit. Rev. Food Sci. Nutr.49,379–404 (2009).▪ Provides details on tea chemistry.
  Medline CASGoogle Scholar
• 39  Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H. Cancer prevention by tea: evidence from laboratory studies. Pharmacol. Res.64,113–122 (2011).
  Medline CASGoogle Scholar
• 40  Henning SM, Wang P, Heber D. Chemopreventive effects of tea in prostate cancer: green tea versus black tea. Mol. Nutr. Food Res.55,1–16 (2011).
  Google Scholar
• 41  Pandey M, Gupta S. Green tea and prostate cancer: from bench to clinic. Front. Biosci. (Elite Ed.)1,13–25 (2009).
  MedlineGoogle Scholar
• 42  Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr.43,89–143 (2003).
  Medline CASGoogle Scholar
• 43  Shirakami Y, Shimizu M, Moriwaki H. Cancer chemoprevention with green tea catechins: from bench to bed. Curr. Drug Targets13,1842–1857 (2012).
  Medline CASGoogle Scholar
• 44  Yang CS, Wang H. Mechanistic issues concerning cancer prevention by tea catechins. Mol. Nutr. Food Res.55,819–831 (2011).▪ Provides an excellent overview on mechanisms of chemoprevention by tea polyphenols.
  Medline CASGoogle Scholar
• 45  Gupta K, Thakur VS, Bhaskaran N et al. Green tea polyphenols induce p53-dependent and p53-independent apoptosis in prostate cancer cells through two distinct mechanisms. PLoS ONE7,e52572, (2012).
  Medline CASGoogle Scholar
• 46  Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (–)-epigallocatechin-3-gallate. Cancer Res.66,2500–2505 (2006).
  Medline CASGoogle Scholar
• 47  Thakur VS, Gupta K, Gupta S. Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis33,377–384 (2012).
  Medline CASGoogle Scholar
• 48  Lee MH, Han DW, Hyon SH, Park JC. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB. Apoptosis16,75–85 (2011).
  Medline CASGoogle Scholar
• 49  Renouf M, Marmet C, Guy PA et al. Dose-response plasma appearance of green tea catechins in adults. Mol. Nutr. Food Res.57,833–839 (2013).
  Medline CASGoogle Scholar
• 50  Borges G, Lean ME, Roberts SA, Crozier A. Bioavailability of dietary (poly)phenols: a study with ileostomists to discriminate between absorption in small and large intestine. Food Funct.4,754–762 (2013).
  Medline CASGoogle Scholar
• 51  Lambert JD, Sang S, Lu AY, Yang CS. Metabolism of dietary polyphenols and possible interactions with drugs. Curr. Drug Metab.8,499–507 (2007).
  Medline CASGoogle Scholar
• 52  Lambert JD, Sang S, Yang CS. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Mol. Pharm.4,819–825 (2007).
  Medline CASGoogle Scholar
• 53  Sang S, Lambert JD, Ho CT, Yang CS. The chemistry and biotransformation of tea constituents. Pharmacol. Res.64,87–99 (2011).
  Medline CASGoogle Scholar
• 54  Henning SM, Choo JJ, Heber D. Nongallated compared with gallated flavan-3-ols in green and black tea are more bioavailable. J. Nutr.138,S1529–S1534 (2008).
  Medline CASGoogle Scholar
• 55  Fang M, Chen D, Yang CS. Dietary polyphenols may affect DNA methylation. J. Nutr.137,S223–S228 (2007).
  Medline CASGoogle Scholar
• 56  Meng X, Sang S, Zhu N et al. Identification and characterization of methylated and ring-fission metabolites of tea catechins formed in humans, mice, and rats. Chem. Res. Toxicol.15,1042–1050 (2002).
  Medline CASGoogle Scholar
• 57  Renouf M, Redeuil K, Longet K et al. Plasma pharmacokinetics of catechin metabolite 4´-O-Me-EGC in healthy humans. Eur. J. Nutr.50,575–580 (2011).
  Medline CASGoogle Scholar
• 58  Wang P, Aronson WJ, Huang M et al. Green tea polyphenols and metabolites in prostatectomy tissue: implications for cancer prevention. Cancer Prev. Res. (Phila.)3,985–993 (2010).▪▪ First time (–)-epigallocatechin gallate was found in human prostate tissue in men consuming six cups of green tea (GT).
  Medline CASGoogle Scholar
• 59  Henning SM, Niu Y, Lee NH et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am. J. Clin. Nutr.80,1558–1564 (2004).
  Medline CASGoogle Scholar
• 60  Stalmach A, Troufflard S, Serafini M, Crozier A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol. Nutr. Food Res.53(Suppl. 1),S44–S53 (2008).
  Google Scholar
• 61  Lambert JD, Lee MJ, Lu H et al. Epigallocatechin-3-gallate is absorbed but extensively glucuronidated following oral administration to mice. J. Nutr.133,4172–4177 (2003).
  Medline CASGoogle Scholar
• 62  Henning SM, Wang P, Said J et al. Polyphenols in brewed green tea inhibit prostate tumor xenograft growth by localizing to the tumor and decreasing oxidative stress and angiogenesis. J. Nutr. Biochem.23,1537–1542 (2012).▪▪ First evidence of in vivo inhibition of protein and gene expression of DNMT1 by GT administration in C57BL/6 mice.
  Medline CASGoogle Scholar
• 63  Henning SM, Wang P, Abgaryan N et al. Phenolic acid concentrations in plasma and urine from men consuming green and black and potential chemopreventive properties in colon cancer. Mol. Nutr. Food Res.57,483–493 (2013).
  Medline CASGoogle Scholar
• 64  Wang P, Heber D, Henning SM. Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo. Food Funct.3,635–642 (2012).
  Medline CASGoogle Scholar
• 65  Karhunen T, Tilgmann C, Ulmanen I, Julkunen I, Panula P. Distribution of catechol-O-methyltransferase enzyme in rat tissues. J. Histochem. Cytochem.42,1079–1090 (1994).
  Medline CASGoogle Scholar
• 66  Landis-Piwowar KR, Wan SB, Wiegand RA, Kuhn DJ, Chan TH, Dou QP. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols. J. Cell. Physiol.213,252–260 (2007).
  Medline CASGoogle Scholar
• 67  Zhu BT, Shim JY, Nagai M, Bai HW. Molecular modelling study of the mechanism of high-potency inhibition of human catechol-O-methyltransferase by (–)-epigallocatechin-3-O-gallate. Xenobiotica38,130–146 (2008).
  Medline CASGoogle Scholar
• 68  Chen D, Wang CY, Lambert JD, Ai N, Welsh WJ, Yang CS. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies. Biochem. Pharmacol.69,1523–1531 (2005).
  Medline CASGoogle Scholar
• 69  Weng Z, Greenhaw J, Salminen WF, Shi Q. Mechanisms for epigallocatechin gallate induced inhibition of drug metabolizing enzymes in rat liver microsomes. Toxicol. Lett.214,328–338 (2012).
  Medline CASGoogle Scholar
• 70  Lee WJ, Shim JY, Zhu BT. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol. Pharmacol.68,1018–1030 (2005).
  Medline CASGoogle Scholar
• 71  Wong CP, Nguyen LP, Noh SK, Bray TM, Bruno RS, Ho E. Induction of regulatory T cells by green tea polyphenol EGCG. Immunol. Lett.139,7–13 (2011).
  Medline CASGoogle Scholar
• 72  Kato K, Long NK, Makita H et al. Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells. Br. J. Cancer99,647–654 (2008).
  Medline CASGoogle Scholar
• 73  Fang MZ, Wang Y, Ai N et al. Tea polyphenol (–)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res.63,7563–7570 (2003).▪ Original study of the effect of GT polyphenols on DNA methylation in cell culture.
  Medline CASGoogle Scholar
• 74  Montenegro MF, Saez-Ayala M, Pinero-Madrona A, Cabezas-Herrera J, Rodriguez-Lopez JN. Reactivation of the tumour suppressor RASSF1A in breast cancer by simultaneous targeting of DNA and E2F1 methylation. PLoS ONE7,e52231 (2012).
  Medline CASGoogle Scholar
• 75  Nandakumar V, Vaid M, Katiyar SK. (–)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. Carcinogenesis32,537–544 (2011).
  Medline CASGoogle Scholar
• 76  Meeran SM, Patel SN, Li Y, Shukla S, Tollefsbol TO. Bioactive dietary supplements reactivate ER expression in ER-negative breast cancer cells by active chromatin modifications. PLoS ONE7,e37748 (2012).
  Medline CASGoogle Scholar
• 77  Li Y, Yuan YY, Meeran SM, Tollefsbol TO. Synergistic epigenetic reactivation of estrogen receptor-α (ER-α) by combined green tea polyphenol and histone deacetylase inhibitor in ER-α-negative breast cancer cells. Mol. Cancer9,274, (2010).
  MedlineGoogle Scholar
• 78  Katiyar SK, Singh T, Prasad R, Sun Q, Vaid M. Epigenetic alterations in ultraviolet radiation-induced skin carcinogenesis: interaction of bioactive dietary components on epigenetic targets. Photochem. Photobiol.88,1066–1074 (2012).
  Medline CASGoogle Scholar
• 79  Chen H, Landen CN, Li Y, Alvarez RD, Tollefsbol TO. Epigallocatechin gallate and sulforaphane combination treatment induce apoptosis in paclitaxel-resistant ovarian cancer cells through hTERT and Bcl-2 down-regulation. Exp. Cell Res.319,697–706 (2013).
  Medline CASGoogle Scholar
• 80  Lambert JD, Sang S, Hong J et al. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate. Drug Metab. Dispos.34,2111–2116 (2006).
  Medline CASGoogle Scholar
• 81  Landis-Piwowar KR, Huo C, Chen D et al. A novel prodrug of the green tea polyphenol (–)-epigallocatechin-3-gallate as a potential anticancer agent. Cancer Res.67,4303–4310 (2007).
  Medline CASGoogle Scholar
• 82  Meeran SM, Patel SN, Chan TH, Tollefsbol TO. A novel prodrug of epigallocatechin-3-gallate: differential epigenetic hTERT repression in human breast cancer cells. Cancer Prev. Res. (Phila.)4,1243–1254 (2011).
  Medline CASGoogle Scholar
• 83  Gao Z, Xu Z, Hung MS et al. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. Anticancer Res.29,2025–2030 (2009).
  Medline CASGoogle Scholar
• 84  Pandey M, Shukla S, Gupta S. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int. J. Cancer126,2520–2533, (2010).
  Medline CASGoogle Scholar
• 85  Chuang IC, Yoo CB, Kwan JM et al. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2’-deoxycytidine. Mol. Cancer Ther.4,1515–1520 (2005).▪ Demonstrates the difference in inhibition of DNA methylation between (–)-epigallocatechin gallate and nucleoside analog drugs.
  Medline CASGoogle Scholar
• 86  Stresemann C, Brueckner B, Musch T, Stopper H, Lyko F. Functional diversity of DNA methyltransferase inhibitors in human cancer cell lines. Cancer Res.66,2794–2800 (2006).
  Medline CASGoogle Scholar
• 87  Neilson AP, Hopf AS, Cooper BR, Pereira MA, Bomser JA, Ferruzzi MG. Catechin degradation with concurrent formation of homo- and heterocatechin dimers during in vitro digestion. J. Agric. Food Chem.55,8941–8949 (2007).
  Medline CASGoogle Scholar
• 88  Neilson AP, Song BJ, Sapper TN, Bomser JA, Ferruzzi MG. Tea catechin auto-oxidation dimers are accumulated and retained by Caco-2 human intestinal cells. Nutr. Res.30,327–340 (2010).
  Medline CASGoogle Scholar
• 89  Yang GY, Liao J, Li C et al. Effect of black and green tea polyphenols on c-jun phosphorylation and H(₂)O(₂) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis21,2035–2039 (2000).
  Medline CASGoogle Scholar
• 90  Gros C, Fahy J, Halby L et al. DNA methylation inhibitors in cancer: recent and future approaches. Biochimie94,2280–2296 (2012).
  Medline CASGoogle Scholar
• 91  Karahoca M, Momparler RL. Pharmacokinetic and pharmacodynamic analysis of 5-aza-2´-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy. Clin. Epigenetics5,3 (2013).
  Medline CASGoogle Scholar
• 92  Juergens RA, Wrangle J, Vendetti FP et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov.1,598–607 (2011).
  Medline CASGoogle Scholar
• 93  Navarro-Peran E, Cabezas-Herrera J, Garcia-Canovas F, Durrant MC, Thorneley RN, Rodriguez-Lopez JN. The antifolate activity of tea catechins. Cancer Res.65,2059–2064 (2005).
  Medline CASGoogle Scholar
• 94  Navarro-Peran E, Cabezas-Herrera J, Campo LS, Rodriguez-Lopez JN. Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate. Int. J. Biochem. Cell Biol.39,2215–2225 (2007).
  Medline CASGoogle Scholar
• 95  Abali EE, Skacel NE, Celikkaya H, Hsieh YC. Regulation of human dihydrofolate reductase activity and expression. Vitam. Horm.79,267–292 (2008).
  Medline CASGoogle Scholar
• 96  Correa A, Stolley A, Liu Y. Prenatal tea consumption and risks of anencephaly and spina bifida. Ann. Epidemiol.10,476–477 (2000).
  Medline CASGoogle Scholar
• 97  Lemos C, Peters GJ, Jansen G, Martel F, Calhau C. Modulation of folate uptake in cultured human colon adenocarcinoma Caco-2 cells by dietary compounds. Eur. J. Nutr.46,329–336 (2007).
  Medline CASGoogle Scholar
• 98  Saez-Ayala M, Sanchez-del-Campo L, Montenegro MF et al. Comparison of a pair of synthetic tea-catechin-derived epimers: synthesis, antifolate activity, and tyrosinase-mediated activation in melanoma. Chem. Med. Chem.6,440–449 (2011).
  CASGoogle Scholar
• 99  Yen TT, Gill AM, Frigeri LG, Barsh GS, Wolff GL. Obesity, diabetes, and neoplasia in yellow A(vy)/- mice: ectopic expression of the agouti gene. FASEB J.8,479–488 (1994).
  Medline CASGoogle Scholar
• 100  Wolff GL, Kodell RL, Moore SR, Cooney CA. Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J.12,949–957 (1998).
  Medline CASGoogle Scholar
• 101  McCabe MT, Low JA, Daignault S, Imperiale MJ, Wojno KJ, Day ML. Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. Cancer Res.66,385–392 (2006).
  Medline CASGoogle Scholar
• 102  Volate SR, Muga SJ, Issa AY, Nitcheva D, Smith T, Wargovich MJ. Epigenetic modulation of the retinoid X receptor α by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer. Mol. Carcinog.48,920–933 (2009).
  Medline CASGoogle Scholar
• 103  Mittal A, Piyathilake C, Hara Y, Katiyar SK. Exceptionally high protection of photocarcinogenesis by topical application of (–)-epigallocatechin-3-gallate in hydrophilic cream in SKH-1 hairless mouse model: relationship to inhibition of UVB-induced global DNA hypomethylation. Neoplasia5,555–565 (2003).
  Medline CASGoogle Scholar
• 104  Morey K, Zhang W, Pascual M et al. Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate. Cancer Prev. Res. (Phila.)2,1065–1075 (2009).
  MedlineGoogle Scholar
• 105  Adhami VM, Siddiqui IA, Sarfaraz S et al. Effective prostate cancer chemopreventive intervention with green tea polyphenols in the TRAMP model depends on the stage of the disease. Clin. Cancer Res.15,1947–1953 (2009).
  Medline CASGoogle Scholar
• 106  Harper CE, Patel BB, Wang J, Eltoum IA, Lamartiniere CA. Epigallocatechin-3-gallate suppresses early stage, but not late stage prostate cancer in TRAMP mice: mechanisms of action. Prostate67,1576–1589 (2007).
  Medline CASGoogle Scholar
• 107  Nair S, Hebbar V, Shen G et al. Synergistic effects of a combination of dietary factors sulforaphane and (–)-epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. Pharm. Res.25,387–399 (2008).
  Medline CASGoogle Scholar
• 108  Nair S, Barve A, Khor TO et al. Regulation of Nrf2- and AP-1-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells. Acta Pharmacol. Sin.31,1223–1240 (2010).
  Medline CASGoogle Scholar
• 109  Choi KC, Jung MG, Lee YH et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res.69,583–592 (2009).
  Medline CASGoogle Scholar
• 110  Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Semin. Oncol.38,724–733 (2011).
  Medline CASGoogle Scholar
• 111  Tsang WP, Kwok TT. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J. Nutr. Biochem.21,140–146 (2010).
  Medline CASGoogle Scholar
• 112  Olthof MR, Hollman PC, Zock PL, Katan MB. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am. J. Clin. Nutr.73,532–538 (2001).
  Medline CASGoogle Scholar
• 113  Yuasa Y, Nagasaki H, Akiyama Y et al. Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients. Carcinogenesis26,193–200 (2005).
  Medline CASGoogle Scholar
• 114  Yuasa Y, Nagasaki H, Akiyama Y et al. DNA methylation status is inversely correlated with green tea intake and physical activity in gastric cancer patients. Int. J. Cancer124,2677–2682 (2009).▪▪ Demonstrates a correlation between high GT intake and DNA methylation status.
  Medline CASGoogle Scholar
• 115  Lim U, Song MA. Dietary and lifestyle factors of DNA methylation. Methods Mol. Biol.863,359–376 (2012).
  Medline CASGoogle Scholar
• 116  Jacob RA, Gretz DM, Taylor PC et al. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr.128,1204–1212 (1998).
  Medline CASGoogle Scholar
• 117  Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA methylation decreases in response to moderate folate depletion in elderly women. Am. J. Clin. Nutr.72,998–1003 (2000).
  Medline CASGoogle Scholar
• 118  Pufulete M, Al-Ghnaniem R, Khushal A et al. Effect of folic acid supplementation on genomic DNA methylation in patients with colorectal adenoma. Gut54,648–653 (2005).
  Medline CASGoogle Scholar
• 119  Morey K, Zhang W, Pascual M et al. Lack of evidence for green tea polyphenols as DNA methylation inhibitors in murine prostate. Cancer Prev. Res. (Phila.)2,1065–1075, (2009).
  MedlineGoogle Scholar